Roche delivers strong 2012 results
Basel, 30 January 2013
Group sales rise 4%1 to 45.5 billion Swiss francs
due to oncology sales, clinical laboratory business
Core EPS 10% higher at 13.62 Swiss francs
Operating free cash flow rises 10% to 15.4 billion Swiss
francs
HER2-franchise...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news